From the latest healthcare headlines to MedAxiom community news, this is the place to learn more and stay informed. Updated regularly.
Partner News | Published: Thursday, July 9, 2020
Learn how ScImage’s PICOM365 provides a turnkey end-to-end solution for data and image integration in this white paper that was developed in partnership with ScImage. Hear from MedAxiom members that have chosen their solution and the benefits they have experienced in workflows and overall work-life balance.
Partner News | Published: Thursday, June 4, 2020By: Robert J. Zasa, CEO, ACA Cardiovascular, LLC and email@example.com Heather Combs, RN , COO, ACA Cardiovascular firstname.lastname@example.org Interventional cardiovascular
Partner News | Published: Monday, June 1, 2020
Cell>Point, LLC. is a leader in the development and commercialization of molecular imaging and targeted therapeutics.
Partner News | Published: Wednesday, May 20, 2020
Many factors influence your decision to execute a sale-leaseback of your building, including deal terms, asset location, strength of the practice, and tenure of the physicians. In this white paper from Physicians Realty Trust, a trusted industry partner, learn what factors to consider as you determine if the timing is right to look at a potential sale-leaseback for your real estate.
Partner News | Published: Wednesday, May 13, 2020Genetesis Inc, a MedAxiom partner and medical technology company that has developed non-invasive, biomagnetic CardioFlux™ imaging, has announced several important updates. The company has closed
Partner News | Published: Monday, May 11, 2020Medical practices are working through multiple issues brought on by the COVID-19 pandemic: supplying needed care for patients, uncertainties in staffing, PPE supply, PPP funding, and preserving revenue. Some
Farxiga approved in the US for the treatment of heart failure in patients with heart failure with reduced ejection fraction
Partner News | Published: Thursday, May 7, 2020AstraZeneca’s Farxiga (dapagliflozin) has been approved in the US to reduce the risk of cardiovascular (CV) death and hospitalisation for heart failure in adults with heart failure (NYHA class II-IV)
Partner News | Published: Monday, May 4, 2020As we emerge from the unprecedented COVID-19 crisis, programs across the country are seeking a safe, rational approach to re-opening their Cath Labs and resuming elective revascularization. MedAxiom Industry
Partner News | Published: Wednesday, April 29, 2020TDK Corporation (TSE:6762) announces that subsidiary TDK Ventures Inc. adds to its growing portfolio of companies with an investment in Genetesis, a world leader in non-invasive biomagnetic imaging. Genetesis
Partner News | Published: Wednesday, April 29, 2020COVID-19, or the Coronavirus, has been the source of widespread concern across the country. This is a severe illness for those with a compromised immune system such as the elderly or those with preexisting